Immunohistochemistry based assay to determine the effects of treatments on Cryptosporidium parvum viability.
Cell culture infectivity assays can provide an accurate means of detecting viable Cryptosporidium parvum oocysts from environmental samples or to test the effects of various treatments on oocyst infectivity. Cell culture assays can also be used to test candidate chemotherapeutic agents. The use of a human cell line provides a situation close to human infection. The present assay uses an anti-Cryptospordium primary antibody, combined with a biotinylated secondary antibody, and an immunoperoxidase detection system. Cryptosporidium parvum oocysts excysted in vitro when placed on monolayers of HCT-8 cells and developmental stages including schizonts and merozoites were visualized using light microscopy of the immunoperoxidase stained slides and by transmission electron microscopy of infected HCT-8 cell cultures. Because the immunoperoxidase system used gives a permanent preparation, the cell cultures can be retained and examined later. Dose titration of oocysts indicated that as few as 50 inoculated oocysts could be detected. The activity of paromomycin was evaluated in this system and 500 microg/ml produced a 97.8% reduction in infection.
Phelps
K K
KK
Department of Food Science and Technology, Virginia Tech, Blacksburg, USA.
Lindsay
D S
DS
Sumner
S S
SS
Fayer
R
R
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016785:Cryptosporidium parvum / Q000187:drug effects* / Q000254:growth & development* / Q000472:pathogenicity; D007150:Immunohistochemistry / Q000379:methods; D021261:Parasitic Sensitivity Tests / Q000379:methods; D010303:Paromomycin / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D000900:Anti-Bacterial Agents; D010303:Paromomycin